Fisher And Paykel Healthcare Corpo revenue and financials

FPH · ASX · AUD

$37.69+0.96%+$0.36

Close · October 7, 2026

In the fiscal year ended March 2026, Fisher And Paykel Healthcare Corpo reported revenue of $2.31B (+80.30% year over year). Net income was $468.5M, a net margin of 20.3%.

Annual revenue · 2026: $2.31B

$1.59B2023
$1.76B2024
$1.28B2025
$2.31B2026

Fiscal year ending in March. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: +80.30%; FY to Mar 2026 vs FY to Mar 2025
Net income growth: +24.20%; FY to Mar 2026 vs FY to Mar 2025
Net margin: 20.3%; FY to Mar 2025: 29.5%

Financial data

Amounts in millions of NZD; per-share values in NZD; shares in millions.

Income statement · Quarterly
Item	Q1 2025
Total revenue	1,280
Cost of revenue	750
Gross profit	530
Selling, general and administrative	534
Research and development	227
Operating income	-371
EBIT	514
EBITDA	654
Interest expense	11.1
Pre-tax income	503
Income tax	126
Net income	377
Net income to common shareholders	377
Basic EPS	0.64
Diluted EPS	0.64
Average shares (basic)	586
Average shares (diluted)	590